Big Pharma Leverages Early-Stage Risk with Innovative Options

Article

In recent years, large pharmaceutical companies have launched a variety of initiatives to restock ailing pipelines and boost business performance including mergers and acquisitions, diversifying business portfolios to non-pharmaceutical products, downsizing, spinoffs, and entering the biopharmaceutical arena.

Recent Videos
Preeya Beczek, managing director and co-founder of Beczek.COM, chats about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Kate Coleman, vice president regulatory affairs, quality and compliance, Arriello, chats about industry trends and technological advances.
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Cellino Partners with Karis Bio for Autologous iPSC Therapy to Treat Cardiovascular Disease

Feliza Mirasol
April 18th 2025
Article

This collaboration aims to advance a first-in-human clinical study by using autologous iPSC technology.

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
September 27th 2024
Podcast

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Entos Collaborates with Circio to Develop In-Vivo Delivery of DNA Vectors

Feliza Mirasol
April 10th 2025
Article

Through this collaboration, Circio will combine its circVec DNA vectors with Entos’ Fusogenix PLV delivery technology, which is expected to enhance delivery efficiency and reduce toxicity.

Site Logo

Vaccines and Virus Purification through the Ages

June 11th 2018
Podcast

Learn Morewww.bio-rad.com/fluvaccine

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Sai Life Sciences Establishes Peptide Research Center at R&D Campus in India

Feliza Mirasol
April 7th 2025
Article

Rising demand for peptide-based therapeutics prompts the launch of this new peptide research center, which will offer services across peptide synthesis, discovery, and advanced modalities.

Business cooperation strategy to create value for customers achieve the goal. | Image Credit: © Thanadon88 - stock.adobe.com

Adopting Flexible Strategies to Combat Capacity Shortages

Patrick Lavery
April 3rd 2025
Article

More and more contract manufacturers have been looking not at what the state of the supply chain is right now, but what it may be in the next three to five years.

© 2025 MJH Life Sciences

All rights reserved.